The return of the minimum clinically important difference for 6-minute-walk distance in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 4, 2013, Pages 335-336

  Holland, Anne E ^a,b   Nici, Linda ^c,d  

^a LA TROBE UNIVERSITY   (Australia)

^b INSTITUTE FOR BREATHING AND SLEEP   (Australia)

^c BROWN UNIVERSITY   (United States)

^d PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 MINUTE WALK DISTANCE; ANALYTICAL PARAMETERS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; DEATH; DEPRESSION; EDITORIAL; HAZARD RATIO; HOSPITALIZATION; HUMAN; MINIMUM CLINICALLY IMPORTANT DIFFERENCE; MORTALITY; MUSCLE WEAKNESS; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; RELIABILITY; SURVIVAL; VALIDITY; WALKING;

EXERCISE TEST; FEMALE; HOSPITALIZATION; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84873951328     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201212-2191ED     Document Type: Editorial

References (16)

1. American Thoracic Society. ATS statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med 2002;166:111-117.
2. Hernandes NA, Wouters EFM, Meijer K, Annegarn J, Pitta F, Spruit MA. Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J 2011;38:261-267.
3. Wijkstra PJ, TenVergert EM, van der Mark TW, Postma DS, Van Altena R, Kraan J, Koeter GH. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax 1994;49:468-472.
4. Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-Collazo E, Alvarez-Sala R. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009;180:506-512.
5. Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PM, Pinto- Plata V, Celli BR, Tal-Singer R, Wouters EF. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med 2010;104:849-857.
6. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997;155:1278-1282.
7. Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, Schunemann HJ. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 2008;32:637-643.
8. Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010;91:221-225.
9. Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, Wise RA, Sciurba F. The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011;37:784-790.
10. Schunemann HJ, Guyatt GH. Commentary: goodbye M(C)ID! Hello MID, where do you come from? Health Serv Res 2005;40:593-597.
11. Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PMA, Tal-Singer R, Agustí A, Bakke PS, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013;187:382-386.
12. Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life research: how meaningful is it? Pharmacoeconomics 2000;18:419-423.
13. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-1519.
14. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sorensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen city heart study. Am J Respir Crit Care Med 2006;173:79-83.
15. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, Moore AJ, Moxham J, Polkey MI. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007;62:115-120.
16. de Voogd JN, Wempe JB, Koeter GH, Postema K, van Sonderen E, Ranchor AV, Coyne JC, Sanderman R. Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009;135:619-625.